Skip to content

The effect of the therapy of 'combination three methods progression' in patients with neurogenic bowel dysfunction (constipated type): study protocol for a randomized controlled trial

Clinical study on the treatment of constipation in patients with neurogenic bowel by the therapy of 'combination three methods progression'

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041463
Enrollment
Unknown
Registered
2020-12-26
Start date
2021-02-23
Completion date
Unknown
Last updated
2021-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neurogenic bowel dysfunction (constipated type)

Interventions

Sponsors

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients with spinal cord injury diagnosed by CT or MRI who meet the 2011 edition of the American Spinal Injury Association (ASIA) International Standard for Neurological Classification of Spinal Cord Injury: Grades B to D;or meet the diagnostic criteria for cerebral haemorrhage in the 2014 edition of the Chinese Guidelines for the Diagnosis and Treatment of Cerebral Haemorrhage, confirmed by CT or MRI; or meet the diagnostic criteria for cerebral infarction in the 2017 edition of the Chinese Guidelines for the Diagnosis and Treatment of Cerebral Infarction with Integrative Medicine, confirmed by CT or MRI. (2) meet the Roman ? diagnostic criteria for functional constipation; (3) aged 20-80 years; (4) with stable vital signs, clear consciousness and normal communication and expression skills; (5) who sign the informed consent form and submit to the arrangements of the subject group. Note: Only patients who meet the above 5 criteria can be included in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with combined serious primary diseases of the heart, liver, kidney and endocrine system; (2) Pregnant and lactating patients; (3) Patients with severe clotting disorders; (4) Patients with psychiatric disorders; (5) Patients with skin allergies or breakout the treated area; (6) Patients who have already participated in other clinical trials. Note: Patients who meet any of the above criteria should be excluded.

Design outcomes

Primary

MeasureTime frame
Number of spontaneous bowel movements(SBMs) per week;

Secondary

MeasureTime frame
Stool character typing ;Degree of difficulty in defecation;SAS;SDS;GSES;

Countries

China

Contacts

Public ContactYinLi Shen

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

441051683@qq.com+86 19141922245

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 16, 2026